The Problem with Pill Changes: A Personal Tale of Confusion and Concern
As I sit here, my hand trembling slightly as I carefully count out my pills for the day, I can't help but feel a sense of unease. I'm 73 years old, and my daily routine involves taking six different medications, a mix of prescription drugs and over-the-counter remedies. But today, something is different. My trusted blue pill has transformed into a bright yellow capsule, and I'm not alone in my confusion.
This isn't the first time my medication has undergone a color change. A few months ago, my once-white and blue capsule had mysteriously turned into a white and purple concoction, and before that, my pink tablet had morphed into a blue one. These changes are not just cosmetic; they have the potential to be dangerous. Pharmaceutical companies often update the shape, size, and color of medications, which can lead to confusion or, worse, accidental overdoses or missed doses. This is a critical issue, especially for the elderly and those with cognitive impairments.
I've developed a meticulous system to manage my medications. Each morning, I spread them out on the kitchen table, using their distinct colors, shapes, and sizes as a visual aid to ensure I take the correct dosage at the right time. This method works for me, but it's not without its challenges. When a pill arrives with an unfamiliar color, size, or shape, I can't help but wonder if it's a mistake. I take extra care to double-check, as I don't want to risk taking the wrong medication.
The issue is not just about individual confusion. According to a report by the Carnegie Mellon University-supported Civic Science data center, nearly 70% of Americans take at least one over-the-counter drug regularly, and the average adult takes two or more prescription drugs daily. With such widespread reliance on medications, the potential for confusion and errors is immense. The problem is exacerbated by the fact that many people receive their drugs by mail, never having a chance to discuss any changes with a pharmacist.
So, why do pharmaceutical companies change pill colors? The answer lies in patent laws. Generic drug manufacturers are required to change the appearance of their pills to distinguish them from the original brand-name medication. This practice, combined with the fact that pharmacies rotate among generic suppliers, each with their own imprinting methods, creates a confusing and potentially dangerous situation. A 2014 study published in Annals of Internal Medicine found that a change in pill color increased the likelihood of patients discontinuing their medication by 34%, while a change in shape increased this likelihood to a staggering 66%.
The situation is further complicated by the fact that insurance companies can dictate changes in suppliers without notifying patients. These new suppliers may create tablets with different codes and colors, adding another layer of confusion. Once a medication is classified as a generic drug, neither the manufacturer nor the prescribing doctor is obligated to inform the patient about cosmetic changes.
As America ages, with the 65-and-older population increasing, the responsibility of managing medications falls more heavily on individuals. Older adults may struggle with eyesight and cognitive function, making it even more challenging to keep track of their medications. It's a recipe for disaster, especially for those living alone.
So, what can be done to address this issue? Patients can take steps to mitigate the problem. They can request pill packs or blister packs that package all doses for the day separately, making it easier to manage. Online pharmacies like PillPack by Amazon Pharmacy, Accupacrx, CVS Health, and Express Scripts offer these services. Additionally, online pill identifier tools can help patients recognize their medications, but they should not replace a conversation with a pharmacist or doctor.
One potential solution lies in the hands of the Food and Drug Administration (FDA). The FDA could issue guidance to drug manufacturers, encouraging them to standardize the size and shape of generic pills. This would reduce confusion and make it easier for patients to manage their medications. However, this approach may be met with resistance from pharmaceutical companies, as it could impact their ability to differentiate their products.
In the meantime, patients must take an active role in managing their medications. They can ask doctors to write 'dispense as written' on prescriptions to avoid generic versions, which may come with different colors and shapes. But the onus should not be solely on the individual. The FDA and policymakers must recognize the potential dangers of pill changes and take steps to ensure patient safety.
My personal experience with the yellow pill is a reminder of the importance of this issue. No one should have to worry about opening a pill bottle and finding a surprise. It's time for a change in how we manage medications, one that prioritizes patient safety and clarity.
Barbara Wolf, a resident of Birmingham, Alabama, has dedicated her life to helping low-income families through nonprofit work. Her experience with medication management highlights the challenges faced by many older adults and the need for systemic improvements in the pharmaceutical industry.
